- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Irish study promises to revolutionise childhood cancer care | ||
| Do | Can Bioxodes end the dearth of haemorrhagic stroke drugs? | ||
| Do | Roche seeking talks with the US on tariff exemptions | ||
| Do | AstraZeneca joins Tempus, Pathos in cancer AI project | ||
| Do | UK's HIV response is 'failing women' | ||
| Mi | Roche gets EU okay for chest pain algorithm | ||
| Mi | Axtria unveils transformational agentic AI platform for life sciences | ||
| Mi | First drug for rare disease APDS cleared for NHS use | ||
| Mi | Swiss biotech Veraxa vaults to Nasdaq listing with SPAC deal | ||
| Mi | Has trial result burst BMS' Cobenfy bubble? | ||
| Mi | Senior FDA resignations gut drug advertising function | ||
| Di | Data readout puts J&J's bladder cancer drug back on track | ||
| Di | Sky Labs' smart ring tops Apple Watch in AFib comparison | ||
| Di | Roche joins the pharma firms planning big US investments | ||
| Mo | Enhertu poised to move first line in HER2+ breast cancer | ||
| Mo | Trodelvy-Keytruda pairing hits the spot in breast cancer | ||
| Mo | Sanofi's Dupixent gets FDA nod for chronic hives indication | ||
| 18.04. | New FDA head says no more pharma on advisory committees | ||
| 18.04. | GSK cements Blenrep comeback with MHRA approval | ||
| 18.04. | WHO (sans US) finishes draft pandemic preparedness agreement | ||
| 18.04. | Merida raises $121m for Graves drug, and other financings | ||
| 17.04. | Lilly soars on first data for oral obesity candidate | ||
| 17.04. | Tariffs 'could cancel out discounts with biosimilars' | ||
| 17.04. | GSK reprimanded over "shocking error" in Omjjara info | ||
| 17.04. | There's good news for RSV jab firms at delayed ACIP meeting |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
